Mediterranean fever gene mutations in Greek patients with Behcet's disease

K Konstantopoulos1, E Kanta, V Papadopoulos

  • 1First Department of Medicine, University of Athens School of Medicine at Laikon Hospital, Athens, Greece. kkonstan@med.uoa.gr

Abstract

Insights

Pyrin gene mutations, linked to Familial Mediterranean Fever, were investigated in Behcet's disease patients. No increased prevalence of these mutations was found in Greek Behcet's disease cases, suggesting they are not a common cause.

Area of Science:

  • Genetics
  • Immunology
  • Rheumatology

Background:

  • Clinical similarities between Behcet's disease and Familial Mediterranean Fever (FMF) suggest a potential shared pathogenesis.
  • FMF is caused by mutations in the MEFV gene, which codes for pyrin.
  • Investigating pyrin mutations in Behcet's disease could elucidate common underlying mechanisms.

Purpose of the Study:

  • To determine if pyrin mutations are associated with Behcet's disease in a Greek population.
  • To explore the potential genetic link between Behcet's disease and FMF.

Main Methods:

  • Molecular testing for pyrin mutations was conducted on 96 unrelated Greek patients diagnosed with Behcet's disease.
  • Results were compared against a control group of 140 unrelated healthy Greek individuals.

Main Results:

  • No pyrin mutations were detected in the Behcet's disease patient cohort.
  • The frequency of pyrin mutations in Behcet's disease patients was comparable to that in the healthy control group.

Conclusions:

  • Pyrin gene mutations are not more prevalent in Greek patients with Behcet's disease than in the general population.
  • This finding contrasts with studies in other populations, indicating potential ethnic or population-specific genetic factors.
  • Routine screening for pyrin mutations is not recommended for evaluating Greek individuals with suspected Behcet's disease.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
9
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
10
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
15
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
18.2K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.5K
Mutations01:39

Mutations

Overview
94.7K